Pills, power, people: Sociological understandings of the pharmaceutical industry

Sociology

Volumn 40, Issue 2, 2006, Pages 297-314

  Busfield, Joan ^a,b  

^a UNIVERSITY OF ESSEX   (United Kingdom)

^b Unversity's Graduate School   (United Kingdom)

Author keywords

Clinical trials; Drug approval; Pharmaceutical industry; Power; Science

Indexed keywords

EID: 33645568057     PISSN: 00380385     EISSN: None     Source Type: Journal    
DOI: 10.1177/0038038506062034     Document Type: Review

References (50)

1. Abraham, J. (1995) Science, Politics and the Pharmaceutical Industry. London: UCL Press.
2. Abraham, J. and G. Lewis (2000) Regulating Medicines in Europe. London: Routledge.
3. Abraham, J. and T. Reed (2002) 'Progress, Innovation and Regulatory Science in Drug Development', Social Studies of Science 32 (3). 337-369.
4. Abraham, J. and J. Sheppard (1999) The Therapeutic Nightmare. London: Earthscan.
5. ABPI (2003) Facts & Statistics from the Pharmaceutical Industry, URL (consulted Aug. 2004). www.abpi.org.uk?statistics/section.asp?sect=1
6. AD2000 Collaborative Group (2004) 'Long-term Donepezil Treatment in 565 Patients with Alzheimer's Disease (AD2000)', Lancet 363 (9427). 2105-2115.
7. Beral, V. (2003) 'Breast Cancer and Hormone-replacement Therapy in the Million Women Study', Lancet 362 (9382). 419-427.
8. Berg, M. (1997) Rationalizing Medical Work. Cambridge, MA: MIT Press.
9. Blume, S.C. (1992) Insight and Industry. Cambridge, MA: MIT Press.
10. Bodenheimer, T. (2000) 'Uneasy Alliance - Clinical Investigators and the Pharmaceutical Industry', New England Journal of Medicine 342 (20). 1539-1544.
11. Britten, N. (2001) 'Prescribing and the Defence of Clinical Autonomy', Sociology of Health and Illness 23 (4). 478-496.
12. Brown, P. and S.C. Funk (1986) 'Tardive Dyskinesia: Barriers to the Professional Recognition of Iatrogenic Disease', Journal of Health and Social Behavior 27: 116-132.
13. Bury, M. and J. Gabe (1996) 'Halcion Nights: A Sociological Account of a Medical Controversy', Sociology 30 (3). 447-469.
14. Busfield, J. (2003) 'Globalization and the Pharmaceutical Industry Revisited', International Journal of Health Services 33 (3). 581-605.
15. Cohen, J. (2001) Over Dose. New York: Putnam.
16. Colgrove, J. (2002) 'The McKeown Thesis', American Journal of Public Health 92 (5). 725-729.
17. Conrad, P. (2005) 'The Shifting Engines of Medicalization', Journal of Health and Social Behavior 46: 3-14.
18. Conrad, P. and J.W. Schneider (1992) Deviance and Medicalization. Missouri: Mosby.
19. Davidson, R.A. (1986) 'Sources of Funding and Outcome of Clinical Trials', Journal of General Internal Medicine 1: 155-158.
20. Department of Health (2000) Prescriptions Dispensed in the Community, 1989 to 1999: England. London: Department of Health.
21. Department of Health (2003) Prescriptions Dispensed in the Community, 1992 to 2002: England. London: Department of Health.
22. FDA (2004) URL (consulted Jun. 2004): www.fda.gov/cder/about/smallbiz/ faq/htm
23. Galbraith, J.K. (1956) American Capitalism. Boston, MA: Houghton Mifflin.
24. GAO (General Accounting Office) (2002) Prescription Drugs: FDA Oversight of Direct-to-consumer Advertising Has Limitations. Washington: US General Accounting Office.
25. Giddens, A. (1991) Modernity and Self-Identity. London: Polity.
26. Harrison, A. (2003) Getting the Right Medicine? London: King's Fund.
27. Howell, J.D. (1995) Technology in the Hospital. Baltimore, MD: John Hopkins University Press.
28. IMS Health (2002) 'Blockbusters Blast a Highway through Pharma Sales', URL (consulted Nov. 2005). www.ims-global.com/insight/news_story/0203/ news_story_020317.htm
29. IMS Health (2004a) '2003 Global Pharma Sale by Region', URL (consulted Jul. 2004). www.ims-global.com/insight/news_story_040316.htm
30. IMS Health (2004b) 'Top Companies, November 2004', URL (consulted Nov. 2004). http://open.imshealth.com/dept.asp/dept%255Fid=2
31. IMS Health (2004c) 'Generics Flourish as Innovation Stalls', URL (consulted Jul. 2004). www.ims-global.com/insight/news_story_0406/ news_story_040614a.htm
32. IMS Health (2004d) 'Lipitor Leads the Way in 2003', URL (consulted Jul. 2004). www.ims-global.com/insight/news_story/0403/news_story_040316.htm
33. IMS Health (2006) 'Top Companies, November 2005', URL (consulted Feb. 2006). http://www.imshealth.com/dept.asp?dept%255fid=2
34. Kjaegard, L.L. and B. Als-Nielson (2002) 'Association between Competing Interests and Authors' Conclusions', British Medical Journal 325 (7358). 249-252.
35. Latour, B. (1987) Science in Action. Cambridge, MA: Harvard University Press.
36. Lichtenberg, F.R. (2003) The Impact of New Drug Launches on Longevity: 1982-2001. Cambridge, MA: National Bureau of Economic Research.
37. Light, D. (1995) 'Countervailing Powers', in T. Johnson, G. Larkin and M. Saks (eds) Health Professions and the State in Europe, pp. 25-41. London: Routledge.
38. McKeown, T. (1976) The Modern Rise of Population. London: Edward Arnold.
39. Mann, M. (1993) The Sources of Social Power, Vol II. Cambridge: Cambridge University Press.
40. Moncrieff, J. (2002) Is Psychiatry for Sale? London: Institute of Psychiatry.
41. Moynihan, R., I. Heath and D. Henry (2002) 'Selling Sickness: The Pharmaceutical Industry and Disease Mongering', British Medical Journal 324: 886-891.
42. NIHCM (2002) Changing Patterns of Pharmaceutical Innovation. Washington: National Institute for Health Care Management Foundation.
43. PhRMA (2004a) Pharmaceutical Industry Profile 2004. Washington: Pharmaceutical Research and Manufacturers Association.
44. PhRMA (2004b) Principles on Conduct of Clinical Trials and Communication of Clinical Trial Results. Washington: Pharmaceutical Research and Manufacturers Association.
45. Streiner, D. (2002) 'The 2 "Es" of Research Efficacy and Effectiveness', Canadian Journal of Psychiatry 47: 552-556.
46. Tarabusi, C. and G. Vickery (1998) 'Globalization in the Pharmaceutical Industry, part I', International Journal of Health Services 28 (1). 67-105.
47. Warde, A. and E. Shove (1998) 'Inconspicuous Consumption', URL (consulted Aug. 2004). www.comp.lancs.ac.uk/sociology/soc00law.html
48. Weiss, M. and R. Fitzpatrick (1997) 'Challenges to Medicine: The Case of Prescribing', Sociology of Health andIllness 19: 297-327.
49. Wilkin, D., L. Hallam, R. Leavey and D. Metcalfe (1987) Anatomy of Urban General Practice. London: Tavistock.
50. World Health Organization (2003) Technology Appraisal Programme of the National Institute for Clinical Excellence. Geneva: WHO.